D-1251-2019 Class II Terminated

Recalled by Advanced Pharma Inc. — Houston, TX

FDA drug recall D-1251-2019 was initiated by Advanced Pharma Inc. on Apr 26, 2019 and is designated Class II. Reason for recall: Sub-potency The recall status is terminated (terminated Oct 30, 2019). Affected quantity: 560 bags.

Recall details

Product Type
Drugs
Report Date
May 8, 2019
Initiation Date
Apr 26, 2019
Termination Date
Oct 30, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
560 bags

Product description

HYDROmorphone 20 mg/100 mL Injectable Solution, Hydromorphone HCl 20 mg 0.9% Sodium Chloride 100 mL, Sterile single use bag, Compounded Drug, Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404, NDC: 42852-221-10

Reason for recall

Sub-potency

Distribution pattern

Nationwide in the US

Code information

Lot: 01/14/19 0215 22110P Exp. 04/29/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1251-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1251-2019. Report a data issue: hello@regdatalab.com.